1. Siddiqui M, Rakumar V. The high cost of cancer drugs and what we can do about it. Mayo Clinic Proc. 2012;87(10):935–43. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538397/ .
2. Nelson R, Barclay L. Cancer drug linked to fatal adverse effects in patients. Medscape Educ Clin Briefs. http://www.medscape.org/viewarticle/736893 .
3. Morgan, Lewis M. Emerging life sciences companies. In: Risk management for drugs and biologics in the United States, Chapter 16, Second ed. http://morganlewis.com/services/~/media/files/Special-Topics/ERH_pubs/ERH_RiskManagementForDrugsAndBiologicsInTheUnitedStates_ELSCDeskbook .
4. American Cancer Society. Cancer treatment and survivorship facts and figures 2012–2013. http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-033876.pdf .
5. Antos JR. Ensuring access to affordable drug coverage in medicare. http://cms.hhs.gov/Research-Statistics-Data-and-Systems/Research/HealthCareFinancingReview/Downloads/05-06Winpg103.pdf .